UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	May 31, 2022

Accession Number:	0001193125-22-162411
Submission Type:	POS AM
CIK: 0001810182 Company Name: ALX ONCOLOGY HOLDINGS INC File Number: 333-258812